These data suggest that FL leads to further activation of FLT3 mutants and is especially important in light of recent findings of elevated FL levels in acute myeloid leukemia patients in response to chemotherapy.
Introduction
FLT3 is a member of the class III receptor tyrosine kinase family (Gilliland and Griffin, 2002) . It is normally expressed by CD34 þ hematopoietic stem/ progenitor cells, dendritic cells, brain, placenta and gonads (Gilliland and Griffin, 2002) . In leukemia, FLT3 expression is observed at the cells of most patients with acute myeloid leukemia (AML), B-precursor acute lymphoblastic leukemia, blast crisis chronic myelocytic leukemia and a smaller percentage of patients with T-precursor acute lymphoblastic leukemia (Birg et al., 1992; Carow et al., 1996; Drexler, 1996) . The ligand for FLT3 receptor is expressed by most leukemia/lymphoma-derived cell lines and primary AML cells (Brasel et al., 1995; Meierhoff et al., 1995; Drexler, 1996; Zheng et al., 2004) . Interaction of wild-type (wt)FLT3 with FLT3 ligand (FL) causes receptor dimerization, leading to the activation of its tyrosine kinase domain (TKD) and autophosphorylation (Lyman et al., 1993) . Activated FLT3 transduces signals through phosphorylation of phospholipase C; casitas B-lineage lymphoma; Src homology 2 domain-containing phosphotyrosine phosphatase 2; Src homology 2 domain-containing inositol 5-phosphatase; signal transducer and activator of transcription 5 (STAT5); and the Ras/Raf/MAPK and PI3 kinase pathways (Dosil et al., 1993; Rosnet et al., 1996; Lavagna-Sevenier et al., 1998; Marchetto et al., 1999; Zhang et al., 1999; Zhang and Broxmeyer, 2000; . Activation of FLT3 by exogenous FL stimulates the proliferation of primary AML blasts (Lisovsky et al., 1996) . FL also induces autocrine signaling in AML (Zheng et al., 2004) . FLT3/internal tandem duplication (ITD) mutations are present in B24% of patients with AML, while mutations in the activation loop of the TKD occur in about 8% of patients with AML (Gilliland and Griffin, 2002) . Both types of mutations have been reported to lead to constitutive activation of FLT3 in a ligand-independent manner, with resultant transformation of hematopoietic cell lines (Fenski et al., 2000; Tse et al., 2000; Yamamoto et al., 2001) . FLT3/ITD mutations are associated with leukocytosis in AML and with leukemic transformation of myelodysplasia (Horiike et al., 1997; Kiyoi et al., 1997; Meshinchi et al., 2001) . The FLT3/ITD mutations, in particular, are associated with poor prognosis in patients with AML (Iwai et al., 1999; Kiyoi et al., 1999) .
The current body of data regarding the FL-independent activation of FLT3 receptors by FLT3/ITD and FLT3/TKD mutations is derived from transfection of these mutant receptors into cell lines, most of which express FL. To investigate whether FL has a role in the activation of FLT3 mutant receptors, we established FL-deficient murine embryo fibroblast (MEF) cells from FL knockout mice. FLT3 mutants and wtFLT3 were introduced into the FL À/À cells to enable us to test the effects of FL on the different types of FLT3 receptors. FL addition augmented phosphorylation of FLT3 mutants and some downstream signaling proteins. FL stimulation also led to increased survival and anti-apoptosis in these cells. Consistent with in vitro data, FL
mice have decreased survival compared with FL
mice. Recent studies have demonstrated several log induction of FL levels in patients undergoing chemotherapy for AML (Sato et al., 2011) . Our results suggest that FL augments the activation of FLT3 mutants, which is associated with increased proliferation and prolonged survival.
Results

FL addition leads to increased phosphorylation of FLT3 in FL
À/À MEF cells expressing wtFLT3, FLT3/ITD and FLT3/TKD mutants Most of the previously published data establishing the paradigm that FLT3 mutants cause activation of FLT3 receptors in a ligand-independent manner were derived from experiments using cell lines expressing FL. In addition, all the experiments were performed in culture medium with serum which contains FL. This leaves open the possibilities that either ligand expressed by these cells could be having an effect through autocrine, paracrine or intracrine activation of FLT3 mutants or that ligand in the serum could contribute to the activation of the mutant receptors. To eliminate the complicating factor of autocrine, paracrine and intracrine FL expression on mutant FLT3 activation, FL À/À MEF cells were established from FL À/À mice. The FL deficiency in the established FL À/À MEF bulk cells was confirmed by RT-PCR analysis (Figure 1a) . Absence of murine wtFLT3 expression was confirmed by western blotting (data not shown). The FL À/À MEF cells were then transduced by a lentiviral vector containing the wt, ITD or TKD forms of FLT3 and clones were selected by limited dilution. Stable expression was confirmed by western blotting (Figure 1b ). Cells were then cultured in serum-free medium (to eliminate the effect of FL contained in serum) for 16 h before stimulation with and without FL. The addition of FL induced more than a fourfold increase in FLT3 phosphorylation in FL (Figure 2b , lanes 4, 8 and 12 vs lanes 3, 7 and 11). These results strongly suggest that endogenous FL expression strongly contributes to the observed activation of mutant FLT3 receptors.
Exogenous FL augments the phosphorylation of FLT3 and enhances survival and resistance to apoptosis in cell lines expressing FLT3 mutants The possibility of further activation of FLT3 mutant receptors by exogenous FL was also tested in cell lines in which FL autocrine, paracrine or intracrine stimulation of FLT3 receptor might exist. TF1 cells that do not express FLT3 receptor were transfected with constructs containing mutant forms of FLT3. TF1 cells expressing FLT3 mutant receptors were starved for 16 h in serumfree medium and washed once with phosphate-buffered saline (PBS) to deplete soluble FL (either produced by the cells or contained in the serum). These cells were then stimulated with exogenous FL for 15 min. More than twofold enhancement of FLT3 phosphorylation was detected in both TF1/ITD and TF1/TKD cell lines (Figure 3a) . Slightly increased STAT5 phosphorylation (1.8-fold increase in both TF1/ITD and TF1/TKD), serine threonine kinase (AKT) phosphorylation and AKT protein expression were also observed after FL stimulation (Figure 3a) . To assess the functional effect of exogenous FL, TF1/ITD and TF1/TKD cells were cultured in serum-free medium in the absence and presence of FL for 48 h. Apoptosis was assessed by annexin V and 7AAD staining followed by fluorescence activated cell sorter (FACS) analysis. The presence of FL decreased the apoptotic population from 61.27 to 49.54% and from 40.2 to 31.63% in TF1/ITD and TF1/TKD cells, respectively (Figure 3b ). There was no change of cell cycle status in response to FL in these cells (data not shown). Survival assays performed by counting viable cell numbers revealed that exogenous FL increased the survival of TF1/ITD cells cultured in serum-free medium (Figure 3c , Po0.05). However, no significant difference was observed in TF1/TKD cells in the presence and absence of FL (Figure 3c ). This data suggest that the presence of FL augments the activation of FLT3/ITD mutant receptors and can contribute to resistance to apoptosis.
BaF3 is another cell line lacking expression of endogenous FLT3. BaF3 cells transfected with mutant forms of FLT3 were starved in serum-free medium for 16 h and washed with PBS before FL stimulation. The addition of FL increased FLT3 phosphorylation in both BaF3/ITD and BaF3/TKD cells. An increase of mitogen activated protein kinase (MAPK) phosphorylation was also observed (Figure 4a ). In both BaF3/ITD and BaF3/TKD cells, exogenous FL also led to slightly increased phosphorylation of AKT (1.3-and 2.2-fold increase in BaF3/ITD and BaF3/TKD, respectively; Figure 4a (that is, no detectable wtFLT3 by PCR). The rate of homozygous FLT3/ITD mutations is very low (o3% of AML cases) and we had access to only four samples that were in sufficient quantities to thaw with adequate viability and recovery of sufficient protein to carry out the western blots. The blasts were stimulated with 100 ng/ml FL. Consistent with what we observed in the FLT3 mutant cell lines, exogenous FL caused enhanced FLT3 phosphorylation (Figure 6a ). Increased MAPK phosphorylation was also detected in two out of four samples (patients #1 and 2). The survival of AML blasts was assessed by culturing them in complete medium with and without FL for 4 days. The presence of FL increased the survival of AML blasts derived from three of four patient samples (Figure 6b , Po0.05 in patients #2, 3 and 4). Possible mutations involving genes other than FLT3 could occur in patient #1 and overshadow the biological effect of FL. Relatively high level expression of endogenous FL might be another possibility that could diminish the effect of added FL. After colonies were counted, all of the cells in each culture dish were harvested from the methylcellulose, washed and replated in fresh methylcellulose medium to examine their potential to form colonies upon secondary plating; this process was repeated for two more passages to determine the frequency of tertiary and quaternary colonies. Control FL À/À BM cells transduced with GFP control vector alone cultured in the absence and presence of FL exhausted virtually all of their proliferative potential by the fourth passage (Figure 7) . Upon serial replating, the number of colonies from FLT3/ITD and FLT3/TKD transduced FL À/À BM cells cultured in the absence of FL also decreased with each passage (Figure 7 ). In contrast, BM cells from FL À/À mice transduced with FLT3 mutants and cultured in the presence of FL retained their replating activity and continued to produce colonies despite repeated passages (Figure 7, Po0.05) . Besides the increase in colony numbers, there was also a significant increase in colony size from FL À/À BM cells expressing FLT3 mutants stimulated with FL (data not shown).
These results indicate that FL stimulation is able to confer a proliferative advantage and immortalized potential on hematopoietic progenitors expressing FLT3 mutants. Li et al. (2008) demonstrated that FLT3/ITD knock-in mice developed myeloproliferative disease which eventually progressed to mortality by 6-20 months . To determine whether or not expression of FL would have any functional effect on survival, the FL À/À FLT3wt/wt mice were crossed with FL þ / þ FLT3wt/ITD mice followed by cross of the secondgeneration double heterozygotes to generate FL
Endogenous FL shortens the survival of FL
ITD þ / þ mice were followed for the development of fatal myeloproliferative disease and the median survival of the two groups was 187 and 256 days, respectively (Po0.05, Figure 8) . Thus, the presence of endogenous FL significantly decreased the survival of homozygous ITD mice ( 5 cells/ml, and cultured for 24 h in serum-free medium. Cell culture supernatant was then collected by centrifugation and FL concentration was assessed by enzyme-linked immunosorbent assay. (b) Cells were cultured in fresh serum-free medium for 16 h and washed with PBS once before stimulation with FL (100 ng/ml for 15 min). Total cellular protein extracts derived from 1 Â 10 7 cells were immunoprecipitated with anti-FLT3 antibody. The immunoprecipitates were resolved by 8% SDS-PAGE and subjected to immunoblot analysis with the antiphosphotyrosine antibody 4G10 (top panel). The same blot was stripped and reprobed with anti-FLT3 antibody (bottom panel).
FL mediated further activation of FLT3 mutant receptors
The majority of the mice in both groups developed splenomegaly and leukocytosis (data not shown). However, the spleen weight and white blood cell count did not differ significantly between the two groups (Po0.05). By determination of the phenotype by FACS analysis of the BM, in conjunction with blood counts, spleen weight and BM morphology, 88% of the FL (Table 1 ). The in vivo data strongly support a functional role for FL in that it significantly accelerated the progress of fatal myeloproliferative disease.
Discussion
The biochemical characteristics of FLT3/ITD mutations were initially investigated by expressing FLT3/ITD mutations in Cos7 cells (Kiyoi et al., 1998) . These initial studies suggested that FLT3/ITD receptors dimerize in a ligand-independent manner, leading to autophosphorylation of the receptor through constitutive activation of the TKD. FL-independent tyrosine phosphorylation of FLT3 was also observed in Cos7 and 32D cells transfected with FLT3/TKD mutations (Yamamoto et al., 2001) . However, most cell lines express FL and thus the possible contribution of their endogenous FL expression to the activation of FLT3 mutant receptors was not clear. It was previously shown that autophosphorylation of wtFLT3 receptors can occur without exogenous FL stimulation in 32D and BaF3 cells expressing wtFLT3 Zheng et al., 2002) . FL has been shown to stimulate autocrine signaling in primary AML blasts expressing wtFLT3 (Zheng et al., 2004) . In the present study, our use of were resolved by 10% SDS-PAGE and subjected to immunoblot analysis with anti-phosphoSTAT5, anti-phosphoAKT and antiphosphoMAPK antibodies. The same blot was stripped and reprobed with anti-STAT5, anti-AKT, anti-MAPK and anti-HSP90 antibodies. (b) Cells were cultured in serum-free medium for 48 h in the presence and absence of FL (100 ng/ml). The cells were then stained with annexin V and 7AAD followed by FACS analysis. The result shown here is representative of three independent experiments. (c) Cells were cultured in serum-free medium for 4 days in the presence and absence of FL (100 ng/ml). Viable cell numbers were assessed by trypan blue exclusion assay. The result shown here is representative of three independent experiments (bars represent standard deviation in the figure).
FL mediated further activation of FLT3 mutant receptors R Zheng et al level of FL expression driven by the retroviral promoter. The average FL level was B6000 pg/ml in the FL transfected FL À/À MEF cell lines (Figure 2a) , which is similar to the significant surge of FL in plasma measured in patients with AML after chemotherapy. The surge of FL results in a blunting of the inhibitory activity of FLT3 kinase inhibitors in vitro (Sato et al., 2011) .
Thus, it seems likely that part of the phosphorylation of FLT3 mutants observed in Cos7 and 32D cells is at least partially explained by autocrine, paracrine and/or intracrine FL stimulation and/or stimulation by FL contained in the serum. This hypothesis is further supported by the findings that an anti-FLT3 antibody that blocks FL binding to the receptors is able to at least partially block the phosphorylation of FLT3 mutants along with its downstream signaling in BaF3 and 32D cells (Piloto et al., 2005) . Our findings suggest that FL might be required for complete activation of FLT3 mutants.
As to the mechanism that explains this observed stimulation, the possibility that increased stability and/ or decreased turnover of phosphorylated forms in response to FL addition was raised. However, the possibility of decreased turnover is less likely since the FL stimulation was for a short period (15 min) in our experiments. Further studies will be required to investigate the exact mechanism.
Our data suggest that FLT3 mutant receptors still respond to FL with further activation. However, the increase of activation of downstream signaling of FLT3 in response to FL addition is relatively modest in comparison with that of the FLT3 mutant receptor itself. Whether FL-mediated activation of FLT3 mutant receptors induces activation of other unknown signaling pathways requires further investigation. The functional effect (survival and apoptosis) of exogenous FL on FLT3 mutant receptors is of modest effect in the experiment with some of the cell lines and one of four primary AML samples. One possible explanation is the minimization of further effect of added FL by the presence of endogenous FL expression.
In this report, we demonstrate that FL stimulation of mutants of FLT3 contributes to the immortalization and proliferation of FL Figure 4 Exogenous FL augments FLT3 phosphorylation and provides a survival advantage to BaF3 cells expressing FLT3 mutants. (a) Cells were cultured in serum-free medium for 16 h and washed once with PBS once before stimulation with FL (100 ng/ml for 15 min). Total cellular protein extracts derived from 1 Â 10 7 cells were immunoprecipitated with anti-FLT3 antibody. The immunoprecipitates were resolved by 8% SDS-PAGE and subjected to immunoblot analysis with anti-phosphotyrosine antibody 4G10. The same blot was stripped and reprobed with anti-FLT3 antibody. Total protein lysates (50 mg) were resolved by 10% SDS-PAGE and subjected to immunoblot analysis with antiphosphoSTAT5, anti-phosphoAKT and anti-phosphoMAPK antibodies. The same blot was stripped and reprobed with anti-STAT5, anti-AKT, anti-MAPK and anti-HSP90 antibodies. (b) Cells were cultured in serum-free medium for 4 days in the presence and absence of FL (100 ng/ml). Survival was assessed by MTT assay. The result shown here is representative of three independent experiments (bars represent standard deviation in the figure) . (c) Cells were cultured in serum-free medium for 4 days in the presence and absence of FL (100 ng/ml). Viable cell numbers were assessed by trypan blue exclusion assay. The result shown here is representative of three independent experiments (bars represent standard deviation in the figure).
This antibody partially inhibits the proliferation of BaF3/ITD cells (Li et al., 2004) . Finally, endogenous FL decreased the survival of homozygous ITD mice (Sato et al., 2011) . It is noted that FL levels are induced by 450 folds in patients undergoing chemotherapy for AML (Levis et al., 2011) . The induction of high levels of ligand and resultant stimulation of mutant receptors might also account for the failure to achieve thorough inhibition of FLT3 signaling in some FLT3 tyrosine kinase inhibitor clinical trials. As FLT3/ITD and TKD mutants have been identified in B24 and 8% of AML patients, respectively, FL-mediated activation of FLT3 mutant receptors might be contributing to FLT3-mediated leukemogenesis (Nakao et al., 1996; Yokota et al., 1997; Abu-Duhier et al., 2001; Stirewalt et al., 2001; Yamamoto et al., 2001) . For all of the above reasons, FL targeted therapy, either antibodies against FL itself or those that would block the ability of FL to activate FLT3, may be indicated as an adjuvant therapy for the treatment of FLT3 mutant AML. These findings also potentially have important implications regarding other growth factor receptor pathways. Autostimulated growth of leukemia cells has been associated with expression of granulocyte macrophage colony stimulating factor (GM-CSF), stem cell factor (SCF) and vascular endothelial growth factor (VEGF) (Freedman et al., 1993; Pietsch, 1993; Rogers et al., 1994; Bellamy et al., 2001) . Ligand-independent activation of the KIT TKD induced by the KIT G560 and KIT V816 activating mutations has been reported (Furitsu et al., 1993) . Epidermal growth factor receptor (EGFR) kinase domain mutations resulting in constitutive phosphorylation and activation of EGFR have been identified in lung cancer (Pao and Miller, 2005) . Based on the data presented here, it is possible that the activation of these KIT and EGFR mutant receptors still respond to SCF and epidermal growth factor (EGF), respectively, to some degree. Generation of SCF and EGF-deficient cell lines with expression of KIT and EGFR mutants, respectively, would shed light on the generality of these findings.
Materials and methods
Reagents
Recombinant human FL was purchased from PeproTech (Rocky Hill, NJ, USA). Rabbit anti-human FLT3 and anti-STAT5 antibody were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Monoclonal mouse antiphosphotyrosine antibody 4G10 and recombinant protein A-agarose were purchased from Upstate Biotechnology (Lake Placid, NY, USA). Anti-phosphoSTAT5, anti-phosphoAKT, anti-phosphoMAPK, anti-AKT and anti-MAPK antibodies were purchased from Cell Signaling Technology (Cell Signaling, Beverly, MA, USA). Horseradish peroxidase-conjugated secondary antibody and the enhanced chemiluminescence detection system were from Amersham (Arlington Heights, IL, USA).
Establishment of FL
À/À MEF cells Embryos were removed from female FL À/À mice (purchased from Taconic, Hudson, NY, USA) on day 13 or 14 of pregnancy. (a) Cells were cultured in serum-free medium for 16 h and washed once with PBS once before stimulation with FL (100 ng/ml for 15 min). Total cellular protein extracts derived from 1 Â 10 7 cells were immunoprecipitated with anti-FLT3 antibody. The immunoprecipitates were resolved by 8% SDS-PAGE and subjected to immunoblot analysis with anti-phosphotyrosine antibody 4G10. The same blot was stripped and reprobed with anti-FLT3 antibody. Total protein lysates (50 mg) were resolved by 10% SDS-PAGE and subjected to immunoblot analysis with anti-phosphoSTAT5, anti-phosphoAKT and anti-phosphoMAPK antibodies. The same blot was stripped and reprobed with anti-STAT5, anti-AKT, anti-MAPK and anti-HSP90 antibodies. (b) Cells were cultured in serum-free medium for 4 days in the presence and absence of FL (100 ng/ml). The survival of the cells was assessed by MTT assay. The result shown here is representative of three independent experiments (bars represent standard deviation in the figure).
Internal organs and heads were removed. The remainder of the embryos was washed, minced, digested with Trypsin/EDTA and then resuspended in Dulbecco's modified eagle medium (DMEM)-containing 10% fetal bovine serum (FBS) followed by centrifuging at 1000 g for 5 min. The cell pellet was resuspended in DMEM-containing 10% FBS and cultured at 37 1C with 5% CO 2 . After three passages, the cells were transfected with CMV-SV40-large T antigen (kindly provided by Dr Linzhao Cheng, Johns Hopkins University) to immortalize FL À/À MEF cells. The FL À/À MEF cells represent bulk cells after transformation. (DNA iCycler; Bio-Rad) . PCR products were resolved on a 1% agarose gel in the presence of ethidium bromide and photographs were taken under UV transillumination.
DNA constructs and retroviral transduction
The mutant FLT3/ITD sequences were isolated from BM samples from AML patients at our institution by RT-PCR. The ITD fragments were sequenced and used to replace the corresponding wt region in full-length FLT3 cDNA. This ITD resulted in an addition of six amino acids, RTDFRE, after amino acid no. 596. The FLT3/TKD mutation was obtained by mutagenesis of wtFLT3 to substitute nucleotide G of D835 with T resulting in an aspartic acid to tyrosine change (QuickChange Site-Directed Mutagenesis Kit; Stratagene, La Jolla, CA, USA). Both types of mutants were then cloned into the pBabePuro retroviral vector (kindly provided by Dr Alan D Friedman) and pCIneo expression vector (Promega, Madison, WI, USA).
Retrovirus was obtained by harvesting supernatant 48 h after transfection of 293T cells with pBabePuro constructs. FL À/À MEF cells were cultured with virus in the presence of polybrene (8 mg/ml) for 2 days. Stable transfectants were then selected by limiting dilution in 96-well plates with 2 mg/ml puromycin. Experiments were performed on at least two clones selected from the transfectants.
The fragment containing the secreted form of FL-coding sequence was amplified from the pUMVC3-hFLex plasmid (kindly provided by Dr Katharine A Whartenby, Johns Hopkins University) by PCR and cloned into the EF1-CMV-GFP lentiviral vector (kindly provided by Dr Linchao Cheng, Johns Hopkins University). Viral stocks were generated and transduction of cells was conducted as described above. GFP-positive cells were sorted by flow cytometry.
TF1 and BaF3 cells were transfected with pCINeo constructs containing either FLT3/ITD or FLT3/TKD mutation by electroporation (Bio-Rad). Stable transfectants were then selected by limiting dilution in 96-well plates with 1 mg/ml G418 (Invitrogen).
Colony-replating assay BM was harvested from FL À/À mice, lineage depleted (Lineage Cell Depletion kit; Militenyi Biotec, Auburn, CA, USA) and transduced with EF1-ITD-UBC-GFP, EF1-TKD-UBC-GFP or EF1-UBC-GFP lentivirus by three rounds of spin-infection on days 1, 2 and 3. The EF1-ITD-UBC-GFP vector was constructed by inserting full-length FLT3/ITD in EF1-UBC-GFP lentiviral vector (kindly provided by Dr L Cheng). The EF1-TKD-UBC-GFP was constructed by inserting wtFLT3 into the EF1-UBC-GFP followed by mutagenesis of wtFLT3 to substitute nucleotide G of D835 with T resulting in an aspartic acid to tyrosine change (QuickChange SiteDirected Mutagenesis Kit; Stratagene). GFP-positive cells were then sorted by FACS. In all, 10 3 cells were plated into triplicate 35 mm petri dishes (Nunc, Roskilde, Denmark) in 1 ml of Methocult M3434 (StemCell Technologies Inc., Vancouver, BC, Canada) containing 50 ng/ml rm SCF, 10 ng/ml rm interleukin-3, 10 ng/ml rh interleukin-6 and 3 units/ml rh erythropoietin. Cultures were incubated at 37 1C in a humidified atmosphere of 5% CO 2 and colonies consisting of 435 cells were scored after 11 days. For the colony-replating assay all cells from the previous culture were collected and replated at 1 Â 10 4 cells/plate in fresh methylcellulose medium. All cells were replated three times.
Generation of mice with FL
FLT3wt/wt C57/Bl6 mice were crossed with FL þ / þ FLT3wt/ITD C57/Bl6 knock-in mice previously generated in the laboratory (Li et al., 2008) . Heterozygotes with the genotype of FL þ /À FLT3wt/ITD were then crossed to generate the desired FL
Genotypes were analyzed by PCR with the following primers: ITD,
þ / þ mice was followed up to 525 days. White blood cell differential counting was performed by collecting 50 ml peripheral blood and subjecting it to analysis using a Hemavet950 Hematology system (Drew Scientific, Oxford, CT, USA). Murine internal organs were dissected from moribund mice and subjected to gross examination. BM was collected and subjected to histological and flow cytometry analysis. All animal procedures were conducted in conformity with institutional guidelines.
Immunoprecipitation and western blot analysis Cells were washed twice with ice-cold PBS and lysed for 30 min in ice-cold NP-40 lysis buffer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 100 mM NaF, 10% glycerol, 1% NP-40 and 10 mM EDTA) containing protease inhibitors (Roche, Indianapolis, IN, USA). Clarified lysates (500 mg) were incubated with rabbit polyclonal antibody to human FLT3 followed by incubation with protein A-agarose at 4 1C. The immunoprecipitates were washed three times with ice-cold tris buffered saline with Tween 20 (TBS-T) (10 mM Tris-HCl, pH 7.4, 100 mM NaCl, 0.1% Tween-20), resuspended in sodium dodecyl sulfate (SDS) sample buffer, heated and separated by SDS-polyacrylamide gel electrophoresis (PAGE) in 8% gels. Gels were blotted onto polyvinylidene fluoride microporous membrane (Millipore, Bedford, MA, USA) and stained with the indicated antibody. Antibody binding was detected by incubation with a horseradish peroxidase-conjugated secondary antibody, followed by chemiluminescence detection. For detection of phosphorylation or protein expression of STAT5, AKT or MAPK, total protein lysates (50 mg) were loaded, separated by PAGE and transferred onto polyvinylidene fluoride membrane. The blot was first probed with anti-phosphoSTAT5, anti-phosphoAKT and anti-phosphoMAPK antibodies. The same blot was stripped and reprobed with anti-STAT5, anti-AKT, anti-MAPK and anti-HSP90 antibodies.
Apoptosis and survival assay Evaluation of apoptosis was performed by annexin V/7-AAD staining according to the recommendations of the manufacturer (Becton Dickinson, San Jose, CA, USA). After serum starvation, 5 Â 10 5 cells were washed with cold PBS and resuspended in 100 l of binding buffer. Following incubation with 5 ml of annexin V-PE and 5 ml of 7-AAD in the dark for 15 min at room temperature, cells were analyzed by flow cytometry (FACSort, Becton Dickinson) with Cell Quest software (Becton Dickinson). Compensation was performed with samples stained with either annexin V-PE or 7-AAD alone.
In all, 2 Â 10 4 cells in 100 ml serum-free medium were plated into triplicate wells of 96-well plates. Survival was assessed by MTT assay (Roche) and viable cell number counting by trypan blue (GIBCO, Rockville, MD, USA) exclusion according to the manufacturer's instructions.
Detection of FL concentration by enzyme-linked immunosorbent assay Cells were washed with PBS once, plated at 5 Â 10 5 cells/ml and cultured for 24 h in serum-free medium. Cell culture supernatant was collected by centrifugation and FL concentration was assessed according to the manufacturer's instruction (R&D systems, Minneapolis, MN, USA).
Primary AML samples Diagnostic BM samples were obtained under institutional review board-approved protocols from patients with AML at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University (Baltimore, MD, USA) before therapy. Leukemic blast cells were separated by Ficoll-Hypaque (Amersham, Piscataway, NJ, USA) density gradient centrifugation. Cells were cultured in RPMI 1640 medium-containing 10% FBS (Invitrogen).
